Source: Neurobiology of Disease

Complications from endovascular thrombectomy (EVT) can negatively affect clinical outcomes, making the development of a more precise and objective pre...

Schizencephaly is a rare brain anomaly which is increasingly detected in utero. There are limited data on the etiology and outcomes in fetal schizence...

Source: Neurobiology of Disease

Diversity of hnRNP A1, hnRNP A2B1, and hnRNP K immunostaining across hippocampal subregions in Alzheimer's disease.

IntraBio Inc., a leader in the discovery and development of innovative drugs for rare neurodegenerative diseases, announced that the US Food and Drug Administration (FDA) has approved Aqneursa

Source: Neuropharmacology

Source: Neuropharmacology

Source: Neuromuscular Disorders, Volume 43, Supplement 1

This cross-sectional study evaluated de-identified data from the National Collegiate Athletic Association—Department of Defense Grand Alliance from ...

The traditional view of glial cells as mere supportive tissue has shifted, due to advances in technology and theoretical conceptualization, to include...

Myelin oligodendrocyte glycoprotein (MOG) is a myelin protein expressed on the outermost layer of the myelin sheath and oligodendrocyte membranes in the central nervous system, exhibiting strong immunogenicity(Reindl et al., 2019). MOG antibody-associated disease (MOGAD) is an inflammatory demyelinating disease of the central nervous system mediated by MOG antibodies, characterized primarily by lesions or loss of myelin in the white matter, optic nerves, and spinal cord. It presents various clinical phenotypes and exhibits age-related incidence, with a higher occurrence in children than in adults (Banwell et al.,2023).

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system (CNS), affecting up to 100 persons per 100,000 in Europe and North America and leading to progressive disability in young adults (Howard et al., 2016). In more than 85% of cases, MS patients suffer from relapsing-remitting course of the disease (RRMS), in which periods of neurological worsening lasting at least 24 hours are followed by periods of remission characterized by a decrease or complete disappearance of symptoms (Howard et al., 2016).

Neuromodulators act on multiple timescales to affect neuronal activity and behavior. They function as synaptic fine-tuners and master coordinators of ...

Gadolinium-based contrast agents are widely used for meningioma imaging; however, concerns exist regarding their side effects, cost, and environmental...

Resting-state functional MRI (rs-fMRI) can be used to estimate functional connectivity (FC) between different brain regions, which may be of value for...

Non-neuroendocrine tumors account for around 10% of all primary neoplasms of the sella. If meningiomas, craniopharyngiomas, and germ cell tumors are e...

Source: Neurobiology of Disease

Publication date: Available online 27 September 2024